Study of Melatonin for treatment of Nocturia in PD
Single-centre open label exploratory phase IIb pilot study of exogenous oral Melatonin for the treatment of Nocturia in adults with Parkinson’s disease - Study of Melatonin for treatment of Nocturia in PD Single-centre open label exploratory phase IIb pilot study of exogenous oral Melatonin for the treat ...